Although it is currently available in Greece only on an out-of-pocket basis, its potential future reimbursement makes it a key comparator for subsequent analyses
This means that sensitivity periods, treatment plans, treatment results and their longevity will vary from patient to patient
Yes, dose increases are a standard clinical strategy and supported by trial evidence showing that higher doses activate more GLP-1 receptors and restore appetite suppression
However, in murine models, exendin-4 demonstrates about 5,500-fold greater potency in improving glucose control, evidenced by the percentage fall in plasma glucose at 1 hour (87)
*Correspondence: Xiaofang Zhang, [email protected]
Ideally, this screening happens weeks before surgery to allow enough time for proper preparation [15] [16]